This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Gycabiane and Glycemic Control of Prediabetic Subjects

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified February 2012 by Pileje.
Recruitment status was:  Recruiting
Information provided by (Responsible Party):
Pileje Identifier:
First received: December 5, 2011
Last updated: February 9, 2012
Last verified: February 2012
The purpose of this study is to examine the effects of supplementation Glycabiane, a dietary supplement, on glycemic control of overweight prediabetic subjects.

Condition Intervention Phase
Hyperglycemia Dietary Supplement: Glycabiane Dietary Supplement: placebo Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Effect of Glycabiane, a Dietary Supplement, on Glycemic Control of Prediabetic Subjects

Resource links provided by NLM:

Further study details as provided by Pileje:

Primary Outcome Measures:
  • Fast Blood Glucose [ Time Frame: 4 months ]
    Fast blood glucose will be measured before and after 4 months of supplementation and after 2 months of wash-out

Estimated Enrollment: 60
Study Start Date: November 2011
Estimated Study Completion Date: August 2012
Estimated Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Glycabiane, gelule Dietary Supplement: Glycabiane
2 gelule per day for 4 months
Other Name: Dietary supplement
Placebo Comparator: Placebo Dietary Supplement: placebo
2 gelules per day for 4 months

Detailed Description:

Cinnamon's effects on blood glucose have been the subject of many clinical and animal studies; however, the issue of cinnamon intake's effect on fasting blood glucose (FBG) in people with prediabetes still remains unclear.

The main purpose of this study is to examine the effects of supplementation with Glycabiane, a dietary supplement rich in cinnamon extract, on fast blood glucose of overweight prediabetic subjects in a randomized, placebo-controlled, clinical trial.


Ages Eligible for Study:   25 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Male or female from 25 to 65 years old
  • 1.0g/L ≤ fast blood glucose < 1.26g/L
  • overweight (IMC > 25)

Exclusion Criteria:

  • thyroid disease
  • hypogonadism
  • History of musculoskeletal, autoimmune or neurological disease
  • Treatment against thyroid disease, hypoglycemia, hypertension, or anti-coagulant
  • Pregnant or lactating women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01530685

Contact: Karine Clément, Pr +33 1 42 17 79 19

CHU Pitié Salpetriere Recruiting
Paris, France, 75013
Contact: Salwa Rizkalla, Dr    +33 1 42 17 79 81   
Sponsors and Collaborators
Principal Investigator: Karine Clément, MD INSERM U872
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Pileje Identifier: NCT01530685     History of Changes
Other Study ID Numbers: PILEJE-Glyca-0910
Study First Received: December 5, 2011
Last Updated: February 9, 2012

Keywords provided by Pileje:

Additional relevant MeSH terms:
Prediabetic State
Glucose Metabolism Disorders
Metabolic Diseases
Diabetes Mellitus
Endocrine System Diseases processed this record on September 21, 2017